The primary objective is to determine the early diagnosis rate and mortality rate of the Nasopharyngeal Carcinoma (NPC) in the study population. The secondary objective is to determine the incidence of NPC in the study population.
The research is to evaluate the effect of NPC screening, also as an extended study of Screening for Nasopharyngeal Carcinoma in High Risk Populations (NCT00941538). The program was conducted in Xiaolan and Minzhong towns of Zhongshan city in 2012. All participants will be tested for anti-EBV antibody by using serum samples. Participants are stratified into those having high, moderate and low antibody levels, those having moderate antibody levels are invited to retest annually in the following 3 years and those found to have high antibody levels on these occasions are referred to centers for diagnostic workup for NPC.
Study Type
OBSERVATIONAL
Enrollment
25,000
Zhongshan People's Hospital
Zhongshan, Guangdong, China
The early detection rate (stage I and II) of Nasopharyngeal Carcinoma
Time frame: 10 years
The mortality rate of Nasopharyngeal Carcinoma
Time frame: 10 years
The incidence of Nasopharyngeal Carcinoma
Time frame: 10 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.